Initiation, treatment response evaluation, and safety monitoring of angiotensin receptor/neprilysin inhibitors (Sacubitril/Valsartan) in the management of heart failure in India: An expert group recommendations

Angiotensin receptor/neprilysin inhibitors (ARNI) have become a pillar of heart failure (HF) management. Clinicians gain practical insight into the use of sacubitril/valsartan in patients with HF with reduced ejection fraction (EF) from a comprehensive overview based on clinical experience with ARNI...

Full description

Bibliographic Details
Main Authors: Uday M Jadhav, V K Chopra, S Ray, A Oomman
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Indian College of Cardiology
Subjects:
Online Access:http://www.joicc.org/article.asp?issn=1561-8811;year=2023;volume=13;issue=4;spage=141;epage=146;aulast=Jadhav